PIER 88 INVESTMENT PARTNERS LLC

Position in KRYS — Krystal Biotech, Inc.

CIK 1697366 SAN FRANCISCO, CA

Position in KRYS

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$904,120

-$74,643 QoQ

Shares Held

3,500

-11.8% QoQ

Ownership

0.012%

of shares outstanding

% of Portfolio

0.20%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

PIER 88 INVESTMENT PARTNERS LLC holds $8,185,124 across 11 Biotechnology names. KRYS ranks #4 (11.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LGND	Ligand Pharmaceuticals Inc	8,000	$1,597,200
2	DNLI	Denali Therapeutics Inc.	64,800	$1,244,160
3	HALO	Halozyme Therapeutics, Inc.	19,000	$1,227,970
4	KRYS	Krystal Biotech, Inc. This page	3,500	$904,120
5	MDGL	Madrigal Pharmaceuticals, Inc.	1,200	$628,164
6	ABSI	Absci Corp	206,100	$618,300
7	BBIO	BridgeBio Pharma, Inc.	7,700	$571,802
8	INSM	INSMED Inc	3,200	$523,264

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$904,120	3,500	-11.8%	Shares	Sole	2026-05-11
2025-12-31	$978,763	3,970	+3.9%	Shares	Sole	2026-02-04
2025-09-30	$674,344	3,820	0.0%	Shares	Sole	2025-10-31
2025-06-30	$525,097	3,820	-13.8%	Shares	Sole	2025-08-07
2025-03-31	$798,729	4,430	+18.1%	Shares	Sole	2025-05-06
2024-12-31	$587,475	3,750	+6.2%	Shares	Sole	2025-02-12
2024-09-30	$642,565	3,530	+5.1%	Shares	Sole	2024-11-06
2024-06-30	$617,030	3,360	+187.2%	Shares	Sole	2024-08-06
2024-03-31	$208,178	1,170	0.0%	Shares	Sole	2024-05-10
2023-12-31	$145,150	1,170	—	Shares	Sole	2024-02-12
No filing history on record for this holder in this stock.